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Abstract
The present study focuses on the nicotine-induced modulation of mRNA and protein expression of a number of genes involved in
glutamatergic synaptic transmission in rat brain over different time periods of exposure. A subchronic (3 days) but not the chronic (7
or 14 days) administration of nicotine resulted in the up-regulation of Homer2a ⁄ b mRNA in the amygdala while in the ventral
tegmental area (VTA) no change in expression of either Homer2a ⁄ b or Homer1b ⁄ c was observed. Although the increase in
Homer2a ⁄ b mRNA was not translated into the protein level in the amygdala, a slight but significant up-regulation of Homer1b ⁄ c
protein was observed in the same region at day 3. Both Homer forms were up-regulated at the protein level in the VTA at day 3. In the
nucleus accumbens, 14 days of nicotine treatment up-regulated mRNA of Homer2b ⁄ c by 68.2% (P < 0.05), while the short form
Homer1a gene was down-regulated by 65.0% at day 3 (P < 0.05). In regard to other components of the glutamatergic signalling, we
identified an acute and intermittent increase in the mRNA and protein levels of mGluR1 and mGluR5 in the amygdala. In the VTA,
however, the effects of nicotine on mGluR mRNA expression were long-lasting but rather specific to mGluR1. Nevertheless, mGluR1
protein levels in the VTA area were up-regulated only at day 3, as in the amygdala. These data provide further evidence for the
involvement of nicotine in the glutamatergic neuronal synaptic activity in vivo, suggesting a role for the newly identified Homer
proteins in this paradigm.
Introduction
Previous microarray experiments completed in this laboratory to study
the effects of nicotine in different rat brain regions provided a set of
candidate genes that may be responsible for the changed cellular
environment in the presence of nicotine (Konu et al., 2001; Li et al.,
2002). Among them, a candidate gene named Homer2b ⁄VESL2 was
found to be up-regulated by nicotine in the amygdala and ventral
tegmental area (VTA) of the rat brain. Homer proteins can bind to and
regulate the cellular distribution of the metabotropic glutamate
receptors (mGluRs) (Brakeman et al., 1997; Kato et al., 1997; Kato
et al., 1998). Homer proteins also function as scaffolding proteins
connecting the metabotropic glutamate group I receptors (i.e. mGluR1
and mGluR5) to the intracellular phosphatidylinositol signalling
pathway (Tu et al., 1998; Soloviev et al., 2000a).
The Homer family is made up of three genes named Homer1, 2 and 3
that have several alternatively spliced transcripts (Xiao et al., 2000).
The long isoforms of Homer (Homer1b ⁄ c and Homer2a ⁄ b), but not the
short isoform Homer1a, are constitutively expressed (Soloviev et al.,
2000b) and contain a carboxyl terminal coiled-coil domain used in
forming multimeric Homer complexes. The Homer long isoforms are
enriched at postsynaptic sites and coimmunoprecipitate with the group I
mGluRs (Xiao et al., 1998). Homer also associates with the Shank–
PSD-95–NMDA complex, providing a role for mGluR and Homer to
modulate N-methyl-d-aspartate receptors (NMDARs) (Naisbitt et al.,
1999; Tu et al., 1999). Homer1b prevents mGluR5 expression on the
cell surface by keeping it on the endoplasmic reticulum of the secretory
pathway (Roche et al., 1999). Homer1a, on the other hand, does not
impede the expression of mGluR5 and has been shown to increase cell
surface expression of mGluR1a (Ciruela et al., 1999) while preventing
clustering of group I mGluRs (Tu et al., 1998). Further study into
Homer1 proteins reveals a complex interplay of Homer1 isoforms and
the cell surface targeting of mGluR5 upon neuronal excitation (Ango
et al., 2000). Homer is thus becoming an important player in the
postsynaptic response to glutamatergic activation.
mGluRs are coupled to G protein second messenger pathways and
modulate glutamate neurotransmission in the brain. Both the fast
excitatory transmission ionotropic glutamate receptors (iGluRs) and
the mGluRs are involved in neuroplasticity (Ottersen & Landsend,
1997; Anwyl, 1999). NMDA and alpha-amino-3-hydroxy-5-methyl-4-
isopropinonate (AMPA) ionotropic glutamate receptors are known to
participate in long-term potentiation (LTP) and long-term depression
(LTD) of neurons (Asztely & Gustafsson, 1996; Xie et al., 1992). The
number, location and gating characteristics of these ionic receptors are
important in determining synaptic strength. It has been suggested that
drugs of abuse, such as nicotine, that produce long-term neuronal
changes by altering the steady state of intracellular signalling
molecules, share mechanisms similar to those used in learning and
memory (Nestler, 2002).
mGluRs and Homer proteins have been implicated in playing an
important role in neural stimulation and drug addiction (Brakeman
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et al., 1997; Kato et al., 1997; Ango et al., 2000; Chiamulera et al.,
2001; Swanson et al., 2001; Bottai et al., 2002; Paterson et al., 2003).
It has been demonstrated that mGluR5-knockout mice lack the
psychostimulant effect of cocaine injections, and a decrease in
locomotor activity was observed (Chiamulera et al., 2001). These
mice also had no interest in self-administering cocaine. In a separate
study (Swanson et al., 2001), repeated cocaine administration blunted
glutamate release into the nucleus accumbens and resulted in increased
locomotor activity that accompanies intra-accumbens administration
of the group I mGluR agonist (RS)-3,5-dihydroxyphenylglycine
(DHPG). An investigation into this response revealed a decrease in
Homer1b ⁄ c protein levels in the nucleus accumbens, suggesting that
mGluR1 and Homer1b ⁄ c are involved in the neurochemical and
behavioural response to the effects of a drug of abuse like cocaine
(Swanson et al., 2001). Moreover, 2-methyl-6-(phenylethynyl)-pyrid-
ine (MPEP), a specific mGluR5 antagonist, decreased nicotine
self-administration by rodents, providing further support for the
involvement of mGluR5 in mediating the reinforcing effects of the
drugs of abuse (Paterson et al., 2003). Finally, Homer-knockout mice
displayed behavioural and biochemical characteristics similar to those
observed after withdrawal from repeated cocaine administration,
pointing to the role of Homers in sensitivity to drugs of abuse
(Szumlinski et al., 2004).
The neurobiology studies of drug addiction and neuropsychiatric
and many neurodegenerative diseases has focused primarily on
deciphering the framework that comprises the mesocorticolimbic
dopamine system. This system is generally defined by the dopamin-
ergic neurons that originate within the ventromedial mesencephalon,
such as the VTA and the substantia nigra, and terminate in limbic
regions such as the striatum, amygdaloid and accumbal regions, as
well as cortical areas such as the prefrontal cortex. In addition to the
dopaminergic projections, there is a complex arrangement of gluta-
matergic, cholinergic and noradrenergic neurons that profoundly
modulate dopamine’s action and physiological effects (Fallon &
Moore, 1978). The primary reinforcement pathway has been
characterized by the excitation of dopaminergic neurons that project
from the VTA of the midbrain to the nucleus accumbens. Nicotine
administration activates mesolimbic dopaminergic neurons by acting
directly at postsynaptic nicotinic acetylcholine receptors (nAChRs)
within the VTA. Further study has indicated that enhanced
glutamatergic excitation coupled with a depressed GABAergic
inhibition contribute to mesolimbic dopamine plasticity (Pidoplichko
et al., 2004).
The amygdala plays a predominant role in relaying the communi-
cation network between the primary reinforcement motivation toward
an abused drug and the memories that are associated with that action.
The basolateral amygdala has traditionally been associated with
conditioned reinforcement behaviours (Everitt et al., 1989). Lesions of
the amygdala have been shown to disrupt the cue conditioning of
reward-related stimuli such as drug reinforcement (Hayes & Gardner,
2004). Stimulation of basolateral amygdala produced an increase in
dopamine release in the nucleus accumbens, suggesting amygdaloid
influence on the primary motor drive underlying drug reinforcement
(Howland et al., 2002; Phillips et al., 2003).
In the present study, we report the region- and time-specific
differences in the expression of the group I mGluR and Homer mRNA
and protein levels in the nucleus accumbens, amygdala and VTA of
nicotine-treated rats over a period of 3, 7 or 14 days. Based on prior
evidence implicating these proteins in neuronal strength and synaptic
plasticity, we hypothesize that these expressional changes are part of
the cellular mechanisms responsible for the initial physiological
response to nicotine administration.
Materials and methods
Animals, nicotine administration and brain punches
Male Holtzman rats (250–350 g; HSD, Madison, WI, USA) received
nicotine dihydrochloride at a dose of 4.0 mg ⁄ kg ⁄ day in saline
(pH 7.4), or saline alone, by i.p. injection. The dose was determined in
previous studies demonstrating consistent expression levels with the
least amount of behaviour changes (Li et al., 2000). An initiation
phase of 48 h was implemented to habituate the animals to the stress
of the injection; this has been shown to reduce c-fos levels in response
to the stress of i.p. injection (Ryabinin et al., 1999). Moreover, saline-
control rats were handled and treated exactly as the nicotine-treated
group, thereby exposing controls to the same stress-induced effects of
i.p. injection. All experiments had six animals in each of the control
and treatment groups except when noted. Rats were housed in wire-
bottomed cages at 22 C and maintained on a 12 : 12-h light : dark
cycle. Standard laboratory rat chow and water were freely available.
Nicotine was administrated five times a day from 09.00 to 17.00 h at
2-h intervals over a period of 3, 7 or 14 days. After the indicated time
of nicotine administration, rats were injected with a lethal overdose of
sodium pentobarbital (100 mg ⁄mL i.p.) and decapitated, and the
brains were removed immediately for sectioning. Coronal 2-mm
sections were prepared from fresh brains, using a Stoelting tissue slicer
(Chicago, IL, USA). Brain punches from selected brain regions were
excised using a brain punch tissue set from myNeuroLab.com (St
Louis, MO, USA) based on coordinates from Paxinos & Watson
(1986). For the ventral tegmental area, each sample contained a single
1.5-mm-diameter punch that was centred in the dense field of
dopamine-containing cells. For the amygdala region, each sample
contained bilateral 2.0-mm-diameter dissections that were centred in
the basolateral nuclear complex. Each sample for the nucleus
accumbens contained the core and shell of the accumbens dissected
using bilateral 2.0-mm-diameter punches. All procedures were
conducted in accordance with animal use guidelines, with the
approval of our Institutional Animal Care and Use Committee.
RNA isolation, reverse transcription and real-time polymerase
chain reaction (real-time quantitative RT-PCR)
Total RNA was isolated from corresponding regions using TRIzol
reagent according to the manufacturer’s protocol (Qiagen Inc., CA,
USA). Three brain regions were examined in this study: the amygdala,
VTA and nucleus accumbens which are all implicated to play a
significant role in drug addiction. Before use, RNA samples were
treated with RNAse-free DNAse I at 37 C for 30 min. Assessments
were made with respect to the integrity of the samples through
viewing of the eithidium bromide-stained 28S and 18S ribosomal
RNA bands.
Real-time RT-PCR conditions reported here were determined by the
strategy described previously (Li et al., 1997) but some modifications
were made to optimize conditions (Bustin, 2000; Konu et al., 2001).
Briefly, total RNA concentration of each sample was measured in
duplicate using a RIBOGreenTM kit (Molecular Probes, Inc., Eugene,
OR, USA). The 0.5 lg of total RNAwas reverse-transcribed in a final
volume of 20 lL containing 4 lL of 5· reverse transcriptase buffer
(Tris-HCl, pH 8.8, 0.1 m; KCl, 0.5 m; and Triton X-100, 1%), MgCl2,
5 mm; DTT, 10 mm; each dNTP, 0.625 mm; RNasin, 20 units; 50 lm
random hexamers, 1 lL; and SuperScript II RNase H– reverse
transcriptase, 200 U (Gibco BRL Life Technologies, Grand Island,
NY, USA). The RT mixtures were incubated at 42 C for 1 h and then
heated at 95 C for 5 min to inactivate the reverse transcriptase.
Amplification of 4 lL RT mixture (equivalent to 0.1 lg total RNA)
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was carried out using core reagents from the SYBR Green kit (PE
Biosystems, Foster City, CA, USA), 5 lL of 10· SYBR Green PCR
buffer, 4.0 lL of 25 mm MgCl2, 1.0 lL of 12.5 mm dNTP mix with
dUTP, 1 lL of sense or antisense primers (0.1 lg ⁄ lL) and 2.5 U of
AmpliTaq DNA polymerase in a total volume of 50 lL. The real-time
RT-PCRs were initially denatured at 94 C for 3 min and then were
subjected to 40 cycles of denaturation (94 C, 30 s), annealing (60 C,
30 s) and extension (72 C, 45 s). The iCycler (Bio-Rad, Hercules,
CA, USA) was used to perform the real-time quantitative RT-PCR.
After the last cycle, a dissociation curve was run to check for product
purity. Intensity values were based on the incorporation of fluorescent
SYBR Green dye (excitation 497, emission 520 nm; Molecular
Probes) into the double-stranded PCR products and were measured by
the Bio-Rad iCycler. All genes were normalized to 18S RNA
expression level.
The primer sequences used for real-time RT-PCR and related
information on each gene are shown in Table 1. To confirm the
efficacy of the real-time PCR technique and demonstrate that each set
of gene-specific primers accurately estimates a two-fold induction per
PCR cycle, a 10· serial dilution of cDNA was used as template for
amplification of 18S, Homer2a ⁄ b, mGluR1a and mGluR5 genes using
gene-specific primers. The slope of the linear regression demonstrates
a difference ranging from 3.0 to 3.5 cycles between each 10· dilution,
which is very close to the theoretically expected value of 3.3 cycles
(see Table 1). The expression level of each gene was determined using
the calibration method (Winer et al., 1999). Threshold cycles (Ct) were
determined by the iCycler for both the target gene and the
housekeeping gene. In this method, one of the unknown samples is
termed the ‘calibrator sample’; the expression of this sample
is compared against all other samples analysed. The formula used
is: fold induction ¼ 2–[DDCt] where DDCt ¼ [Ct GI (gene of interest,
unknown sample) ) Ct 18S (unknown sample)] ) [Ct GI (threshold
cycles, calibrator sample) ) Ct 18S (calibrator sample)].
Western blotting analysis
Total protein was extracted from rat brain punches obtained from an
independent time-course experiment conducted specifically for protein
analysis under the same paradigm as described above except that three
rats in each of the control and treatment groups were used. Individual
frozen brain punches were suspended in 100 lL of 240 mm Tris–HCl,
pH 6.8, containing 20% b-mercaptoethanol, 8% SDS and 40% (v ⁄ v)
glycerol, and homogenized with the Sonic Dismembrator 550 sonicator
(Fisher Scientific, Houston, TX, USA). Tissue debris were removed by
centrifugation at 12 000 g for 1 h. The supernatant was electrophoresed
using 8% sodium dodecyl sulphate polyacrylamide gel (SDS-PAGE)
followed by blotting to nitrocellulose membranes (Immobilon-P;
Sigma). Blots were then blocked with 2% nonfat dry milk for 1 h at
room temperature and probed with antibodies against group I mGluRs
(BD Sciences, San Jose, CA, USA) and Homers (kindly provided by Dr
Paul Worley, The Johns Hopkins University). The respective dilution of
each antibody was as follows: Homer1b ⁄ c, 1 : 5000 and Homer2a ⁄ b,
1 : 5000; mGluR1, 1 : 2500; mGluR5, 1 : 2500; and a-tubulin,
1 : 2500. Immune complexes were detected with appropriate secondary
antibodies and SuperSignal West Pico Chemiluminescent Substrate
(Pierce Inc., Rockford, IL, USA). Blots were stripped with Restore
Western Blot Stripping Buffer (Pierce Inc.). After it was determined that
the membranes were free of the immunodetection reagents, they were
re-probed with antibodies to a-tubulin (for protein normalization). After
the films were developed, they were scanned on a Microtek ScanMaker
8700 scanner with ScanWizard 5.5 at a resolution of 600 dpi for
quantitative analysis. Scanned images were analysed with ImageQuant
5.1 (Molecular Dynamics, Sunnyvale, CA, USA). Normalized data to
either 18s rRNA or tubulin were analysed using anova (Systat 6.0.
SPSS Inc, Chicago, IL, USA). Significant F-tests were followed by
comparison using the Bonferroni procedure. Comparisons yielding




At day 3 of nicotine administration, an 82% increase in the expression
of the longer form of Homer2a ⁄ b was observed by real-time RT-PCR
analysis (P < 0.05; Fig. 1A) within the amygdala region. Because
long forms of Homers are known to cluster and aid in the intracellular
signalling of group I metabotropic receptors, quantitative real-time
RT-PCR was used to measure the mRNA levels of mGluR1 and
mGluR5 in the amygdala region. As with Homer2a ⁄ b, mRNA
expression levels of mGluR1a (37%, P < 0.05; Fig. 1B) and mGluR5
(45%, P < 0.05; Fig. 1C) were induced on day 3 of nicotine
administration but returned to control levels thereafter (see below
and Fig. 4A for details).
To determine whether the protein levels also reflect an acute
up-regulation by nicotine as shown with the RNA expression studies,
Western blot analysis was employed under the same experimental
model as used for quantitative real-time RT-PCR experiments. While
Table 1. A list of genes and their primers used in real-time quantitative RT-PCR
Gene name Accession number Slope of 10· dilutions Primer sequence (5¢)3¢) Product size (bp)
18S X01117 )3.3 AGA AAC GGC TAC CAC ATC CAA g
TGT TAT TTT TCG TCA CTA CCT CCC
84
Homer1a AAC TCA GAG CCA AGG GCT GA
CAT GAT TGC TGA ATT GAA TGT G
78
Homer1b ⁄ c GCT ATA TTC TCC GCG CAA CCT T
GCA ACT CAA CGA GGC AGA CAA T
116
Homer2a ⁄ b NM053309 )3.5 GAG TGG AAA GCG TGT GTG AG
CGC ATT ACA GAA GCA AAC GGA g
65
mGluR1 NM017011 )3.4 ATC ATT GCC AAA CCT GAG AGG AAC
GCC GTT AGA ATT GGC ATT
141
mGluR5 NM017012 )3.0 TTC TCT GTC CAC CAC CAA CC
TAT TGC TCA CGA ACT GCA CC
51
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we did in fact observe an increase in Homer1b ⁄ c protein levels at
day 3 (16%, P < 0.05), no significant increase in Homer2a ⁄ b protein
levels was present (Fig. 2). Using commercially available monoclonal
antibodies against mGluR1a and mGluR5, we also measured their
protein levels at 3, 7 and 14 days of nicotine administration and found
that mGluR1a was increased by 20% (P < 0.05) by nicotine at day 3
(Fig. 3A). mGluR5 was also shown to be increased by 20%
(P < 0.05) in the amygdala at day 3 (Fig. 3B). Homer1b ⁄ c, mGluR1a
and mGluR5 were all observed to return to control levels by days 7
and 14 of nicotine administration (Fig. 4B).
Ventral tegmental area
Glutamatergic neurotransmission within the VTA is important in
modulating the mesolimbic dopaminergic system, thought to be
critical in the primary reward response to drugs of abuse such as
nicotine. We investigated the levels of the group I mGluRs and
various Homer isoforms because nicotine administration is known to
increase glutamatergic neurotransmission in this region. Western blot
analysis showed an 18% increase in Homer1b ⁄ c (P < 0.05) and a
31% increase in Homer2a ⁄ b (P < 0.05; Fig. 5) proteins without a
significant change at the transcript level at day 3 of nicotine
treatment. Western blotting analysis also showed a significant
increase in mGluR1a protein at day 3 only (15%, P < 0.05;
Fig. 6). No significant changes were observed for mGluR5 at both
the mRNA and protein levels in the VTA at any time point
(Fig. 7B). On the other hand, quantitative real-time RT-PCR
demonstrated a consistent increase in the expression level of
mGluR1a in the VTA (60, 67 and 46% at 3, 7 and 14 days,
respectively, P < 0.05; see Fig. 7A). While the mRNA expression
levels of mGluR1a and Homer2a ⁄ b seemed to be somewhat elevated
over the 14 days, the protein levels of Homer1b ⁄ c, Homer2a ⁄ b and
Fig. 1. Comparison of mRNA expression levels for Homer2a ⁄ b and group I mGluRs between nicotine and saline groups in the amygdala region after 3 days of
nicotine administration. Using gene-specific primers, real-time quantitative RT-PCR showed (A) an 83% increase in Homer2a ⁄ b, (B) a 37% increase in mGluR1a
mRNA level and (C) a 45% increase in mGluR5 mRNA level in the amygdala at day 3. *P < 0.05.
Fig. 2. (A) Western blotting analysis for Homer1b ⁄ c and Homer2a ⁄ b at 3 days of nicotine treatment in the amygdala region. (B) Analysis indicated a 16% increase
in Homer1b ⁄ c protein levels while no change in Homer2a ⁄ b protein levels was observed. *P < 0.05.
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Fig. 3. Western blotting analysis for the group I mGluRs in the amygdala after 3 days of nicotine treatment. Monoclonal antibodies against the group I mGluRs
revealed a complementary 20% increase in protein levels at day 3 in the amygdala for both (A) mGluR1a and (B) mGluR5. *P < 0.05.
Fig. 5. Western blotting analysis for Homer1b ⁄ c and Homer2a ⁄ b in the VTA region. While microarray (data not shown) and quantitative RT-PCR (see Fig. 8) show
no difference in mRNA levels of Homer2a ⁄ b, Western blot demonstrated a 31% increase in protein levels. (A) A representative autoradiograph of Western analysis.
(B) Consistent with an increase in Homer2a ⁄ b levels, Western blot analysis shows an 18% increase in Homer1b ⁄ c protein levels at day 3 in the VTA. *P < 0.05.
Fig. 4. Summary of expression changes in (A) mRNA and (B) protein levels for Homers and group I mGluRs over 14 days of nicotine treatment in the
amygdala. There appears to be an early up-regulation of both mRNA and protein levels of group I mGluRs and Homer genes in the amygdala that return to control
levels thereafter. *P < 0.05.
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mGluR1a dropped to control levels after day 3 in a fashion
analogous to the amygdala region.
Nucleus accumbens
Real-time RT-PCR assays indicated that the short form Homer1a and
mGluR1a mRNA levels in the nucleus accumbens were down-
regulated by 65.3% (Fig. 8A; P < 0.05) and 37.1% (Fig. 8B;
P < 0.05), respectively, in response to 3 days of nicotine administra-
tion. However, no significant differences were detected in these
mRNA levels at 7 or 14 days of nicotine treatment (see Fig. 8D). In
contrast, Homer2b ⁄ c was up-regulated by 68.2% after 14 days of
administration (Fig. 8C; P < 0.05). Similarly, we also assayed for the
expression levels of other genes mentioned in the present study at both
the RNA and protein levels and found that they displayed no
significant differences between the nicotine-treated and saline control
groups in the nucleus accumbens (data not shown).
Discussion
Previous microarray analyses demonstrated that nicotine increased the
constitutive expression of the Homer2a ⁄ b gene (Konu et al., 2001). The
present study confirms the modulation of Homer2a ⁄ b mRNA expres-
sion in nicotine-treated rats. Interestingly, although protein levels of
Homer1b ⁄ c increased by 16% (P < 0.05), Homer2a ⁄ b protein did not
show significant change in the amygdala at day 3 (Fig. 2). It is possible
that the protein levels for Homer2a ⁄ b had already begun to return to
baseline at day 3, at which time the first samples were assayed. As noted
at day 7 in the amygdala, the mRNA and protein levels of the genes
under study were all back to control levels (Fig. 4).
Homer is a scaffolding protein involved in a complex interplay
between membrane receptors and intracellular signalling. It represents
an important link in the modulation of a complicated system driven by
the excitatory amino acid glutamate upon target neurons. Nicotine
affects glutamatergic neurotransmission by acting at nAChRs. nAChRs
are located presynaptically where they modulate the release of
neurotransmitters such as glutamate and postsynaptically where they
affect signalling pathways (McGehee et al., 1995; Wonnacott, 1997;
Aramakis & Metherate, 1998; Guo et al., 1998). Coupled with the
widespread CNS distribution of nAChRs, nicotine administration
affects physiological conditions such as addiction, learning, memory
andmore (Levin, 1992; Levin & Simon, 1998). The cellular adaptations
upon nicotine exposure are of particular interest in attempting to explain
these effects of nicotine. In this report, mRNA and protein expression
analyses suggest that the different forms of Homer and mGluRs are
being regulated by nicotine in these brain regions.
It has been demonstrated that nicotine regulates glutamatergic
neurotransmission within the amygdala region (Girod et al., 2000;
Barazangi & Role, 2001). Our data support this with expression levels
of the two group I metabotropic receptors being acutely up-regulated
in the amygdala after nicotine administration. The use of monoclonal
antibodies against mGluR1 and mGluR5 demonstrated that the
increase in mRNA expression levels was translated into an increase
in protein levels in the amygdala at day 3. The amygdala region is
known to play a central role in conditioned reinforcement (Everitt
et al., 1999; Kalivas & Nakamura, 1999; Koob, 1999; Parkinson et al.,
2001) and in establishing different types of learning and memory
(Maren, 1999; Walker & Davis, 2002). Group I mGluRs are involved
in the formation of synaptic plasticity (O’Connor et al., 1994; Huber
Fig. 7. Summary of the target gene (A) mRNA expression and (B) protein levels presented as the percent change relative to control in the VTA. While the
protein levels of Homer1b ⁄ c and mGluR1a dropped in a similar fashion to that observed in the amygdala, the expression level of mGluR1a remained elevated
throughout the full 14 days of nicotine administration. *P < 0.05.
Fig. 6. Western blot analysis of the group 1 mGluR1 in the VTA. A 15%
increase was observed in mGluR1a protein levels. *P < 0.05.
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et al., 1998; Balschun et al., 1999). Group I mGluRs and Homers can
modulate LTP and affect the firing pattern of the target neuron
(Bortolotto et al., 1999; Zheng & Gallagher, 1992; Brakeman et al.,
1997; Kato et al., 1997; Rodrigues et al., 2002). Through changing the
synaptic strength of the target neuron, these processes are believed to
be involved in the formation of learning and memory (Barnes, 1995;
Kato et al., 1997; Turrigiano & Nelson, 2000). The increase in
glutamatergic activity in response to nicotine administration may be
driving the up-regulation of group I mGluRs, as observed in the
amygdala at day 3, thereby providing a mechanism for a new level of
responsiveness to the presence of glutamate. An up-regulation in the
mGluR and Homer protein levels may help explain a change in
the neuroplasticity within the amygdala region that is responsible for
the formation of learning and memory events associated with nicotine
administration.
mGluRs are also known to function postsynaptically through
interaction with other glutamate receptors such as NMDARs (Naisbitt
et al., 1999; Rodrigues et al., 2002). An up-regulation of both
mGluR1a and Homer proteins may indicate an increased association
with the NMDA receptor (Fig. 9). Tu et al. (1999) demonstrated the
existence of the coupling complex, mGluRs–Homer–Shank–F-actin–
GKAP–PSD-95–NMDAR. This complex places all receptors in close
proximity to one another and also is believed to provide a bridge
allowing for the efficient modulation of postsynaptic LTP via
modulation of the actin cytoskeleton (Tu et al., 1999). NMDA
receptors play an important role in LTP formation and the group I
mGluRs are known to modulate LTP through the NMDA receptors
(Aniksztejn et al., 1991; Fitzjohn et al., 1996; Pisani et al., 1997; Yu
et al., 1997; Rodrigues et al., 2002). Recently, Manahan-Vaughan
et al. (2003) reported an increase in mGluR1 and mGluR5 protein
Fig. 8. A comparison of the mRNA levels of (A) Homer1a and (B) mGluR1a at day 3 and (C) Homer1b ⁄ c at day 14 in the nucleus accumbens of control and
nicotine-treated rats. (D) mRNA expression profiles of Homer1a, Homer1b ⁄ c, Homer2a ⁄ b, mGluR1a and mGluR5 in the nucleus accumbens at different time
points of nicotine administration. *P < 0.05.
Fig. 9. Graphical representation of various interacting components of gluta-
matergic signalling that lead to restructuring of the actin cytoskeleton in the
context of synaptic plasticity. Homer dimers allow for receptor clustering at the
cell surface while increasing the intracellular Ca++ levels via their interaction
with IP3Rs. Homer-1a, on the other hand, may compete with Homer long forms
and thus is able to modulate the strength of the synaptic complexes and
cytoskeletal organization. Abbreviations of genes: AMPA2, ionotropic glu-
tamate receptor AMPA 2; NMDAR2D, NMDA ionotropic glutamate receptor;
mGluR1a, glutamate receptor metabotropic alpha 1; mGluR5, glutamate
receptor metabotropic 5; PSD-95, postsynaptic density protein 95 kDa; GKAP,
guanylate kinase-associated protein; SHANK2, proline-rich synapse associated
protein 2; IP3R, inositol 1,4,5-trisphosphate receptor.
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levels and mGluR5 mRNA levels in the hippocampus after LTP
induction, demonstrating regulation of these genes during LTP. Thus,
it is reasonable to assume that the presence of nicotine increases the
release of glutamate presynaptically from nerve terminals where, upon
activation, postsynaptic metabotropic and ionotropic glutamate recep-
tors modulate LTP in target neurons (see Fig. 9).
The mGluR–Homer–Shank–GKAP–PSD-95–NMDAR complex is
also believed to play a role in the effective control of intracellular
calcium levels through the modulation of the phosphatidylinositol
signalling pathway (Nakanishi, 1994; Kawabata et al., 1998; Emptage
et al., 1999; Tu et al., 1999). An increase in glutamatergic activity at
this complex would indicate an increase in phosphoinositide and
intracellular calcium levels (Fig. 9). In addition, Homer dimers are
connected to F-actin whose reorganization is essential for spine
growth and synapse formation (Sala et al., 2001). In addition to the
up-regulation of mGluRs and Homer proteins, the phosphatidylinos-
itol pathway might be modulated by nicotine via changes in the pool
of available phosphatidylinositol-4,5-bisphosphate (PIP2) levels in the
membrane, which can buffer actin-binding proteins. Nicotine has been
shown to increase calcium levels in different types of neuronal cells
(Barrantes et al., 1995; Sabban & Gueorguiev, 2002). Recently,
Conroy et al. (2003) have identified the PDZ-containing proteins that
are receptor-specifically associated with neuronal nAChRs in the chick
ciliary ganglion. They have suggested that PDZ-associated proteins
may play a role in the maturation of nicotinic synapses as well as the
transduction of the calcium signal to the downstream components. Our
findings therefore directly implicate Homer proteins as intrinsic
components of nAChR signalling at the postsynaptic densities.
The mesolimbic dopaminergic projection is modulated by gluta-
matergic action within the VTA (Kalivas et al., 1989; Taber et al.,
1995). Our data revealed an increase in mGluR and Homer proteins in
the VTA, suggesting a role for mGluR pathways in the glutamatergic
modulation of mesolimbic dopamine neurons. The difference in
responses between VTA and amygdala of Homer2a ⁄ b and mGluR5 at
day 3 may be due to the different glutamatergic input and ⁄ or response
mechanisms utilized by the two separate regions. However, despite the
differences there is a similar up-regulation of these related gene
families at the early time points of nicotine administration. Interest-
ingly, the expression and protein levels of Homers and mGluRs
generally returned to baseline at the later time points, suggesting a new
level of tolerance. Behaviour observation mirrors this chronology with
an increased response to nicotine administration at the earlier time
points than to later administrations. Given the fundamental role the
amygdala and VTA play in the physiological response of an organism
to drug treatment, the increase in Homer and mGluR levels suggest a
role and possible target for the type I mGluR signalling pathway in the
primary reinforcement actions of nicotine.
While nicotine produces a transient activation of mesolimbic
dopaminergic neurons acting at somatic nAChRs (Pidoplichko et al.,
1997), Mansvelder & McGehee (2000) demonstrated that glutamate
release from glutamatergic nerve terminals was facilitated by the
activation of presynaptic a7-containing nAChRs, and is required for
prolonged dopamine release in the nucleus accumbens. Furthermore,
NMDA receptor antagonism in the VTA has been shown to decrease
nicotine-elicited accumbal dopamine release (Schilstrom et al., 1998).
Regardless, further pharmacological experiments will be required to
determine whether the group I metabotropic glutamate signalling
complex acting either at distal sites, such as the amygdala or VTA, or
directly within the nucleus accumbens is involved in nucleus
accumbens dopamine release in response to nicotine.
Our findings also implicated the activity-induced short form of
Homer (i.e. Homer1a) as a potential modulator of the nicotine-induced
synaptic activity within the nucleus accumbens region. The expression
analysis demonstrated a significant decrease in Homer1a and
mGluR1a mRNAs in the nucleus accumbens at the early time point
(Fig. 8A and B), although these transcriptional changes were not
immediately reflected at the level of protein expression. Interestingly, a
previous study (Kato et al., 1998) indicated that LTP induced
expression of Homer1a mRNA but not that of the protein, possibly
due to the rapid Homer1a protein turnover. Homer1a, which lacks a
coiled-coil (CC) domain, was shown to exert negative feedback on
Homer-mediated IP3 signalling possibly by competing with
Homer1b ⁄ c and other long isoforms (CC–Homer), and disrupting
the complex formation between CC–Homer and Shank, a component
of postsynaptic density (PSD; Sala et al., 2003). Furthermore, Sala
et al. (2003) have demonstrated that Homer1a is important for
synaptic plasticity because its presence results in the restructuring of
dendritic spine morphology via changes in the dendritic dimensions
and number and in the molecular composition of PSD components.
Our findings suggest that the nicotine-induced synaptic activity and
calcium signalling may be altered by changes in Homer1a and
mGluR1 expression in the nucleus accumbens. However, the cellular
localization of mGluRs as well as long and activity-induced isoforms
of Homer proteins should be determined upon nicotine treatment
because Homer proteins are known to regulate cell-surface targeting of
mGluRs upon ligand activation (Ango et al., 2002; Minami et al.,
2003). Furthermore, studies that incorporate shorter intervals between
experimental time points may be needed to address in detail the degree
to which Homer1a expression is modulated during the course of
nicotine administration.
In summary, our data provide evidence for the regulation of the
group I mGluRs and Homer proteins in the three brain regions (VTA,
amygdala and nucleus accumbens) by systemic nicotine administra-
tion. This represents the first report demonstrating Homer regulation
by nicotine. Nicotine, acting through presynaptic nAChRs on
glutamatergic terminals, drives glutamate release, thereby regulating
excitatory input on target neurons. Activation of the group I mGluRs,
Homer proteins and the phosphatidylinositol signalling pathway may
reflect a new synaptic state in the target neurons. The change in
synaptic strength of these neurons may be involved in several
physiological responses to nicotine administration. Future experiments
are needed to investigate these connections.
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